Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 8, 2006
Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrationsG E Gutierrez, D Lalka, I R Garrett, et al.Clinical Pharmacology and Therapeutics|May 1, 1984
Effect of carbohydrates on estimated hepatic blood flowC K Svensson, P M Mauriello, S H Barde, et al.The American Journal of Cardiology|July 1, 1983
Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidineB G Hardy, I T Zador, L Golden, et al.Journal of Pharmaceutical Sciences|September 1, 1984
Factors affecting quinidine protein binding in humansD J Edwards, J E Axelson, R L Slaughter, et al.Journal of Pharmaceutical Sciences|September 1, 1982
Species differences in the urinary excretion of the novel primary amine conjugate: tocainide carbamoyl O-beta-D-glucuronideK J Gipple, K T Chan, A T Elvin, et al.Anesthesia and Analgesia|June 1, 1981
Factors influencing serum protein binding of lidocaine in humansP J McNamara, R L Slaughter, J A Pieper, et al.Journal of Chromatography|November 3, 1976
Determination of hydralazine and its metabolites by gas chromatography-mass spectrometryK D Haegele, H B Skrdlant, N W Robie, et al.Research Communications in Chemical Pathology and Pharmacology|April 1, 1980
Dose-dependence of the apparent half-life of phenytoin in the ratA Vicuna, D Lalka, P duSouich, et al.Journal of Clinical Pharmacology|August 1, 1978
Procainamide accumulation kinetics in the immediate postmyocardial infarction periodD Lalka, M G Wyman, B N Goldreyer, et al.Drug Intelligence & Clinical Pharmacy|April 1, 1982
Lidocaine clinical pharmacokineticsJ A Pieper, R L Slaughter, G D Anderson, et al.Pageof 5